#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital absence of bile ducts Familial haemophagocytic lymphohistiocytosis Immunodeficiency congenital Alpha-1 antitrypsin deficiency Ovarian cancer stage III ROHHAD syndrome Glomerulonephritis acute IPEX syndrome Malformation venous Follicular lymphoma stage I B-cell lymphoma Myelofibrosis Hepatoblastoma Paroxysmal nocturnal haemoglobinuria Epileptic encephalopathy More trials…

    Learn about Rare Diseases

    Rett syndrome – Diagnostics Fragile X syndrome – Diagnostics Leukoencephalopathy – Life with Disease Ocular melanoma – Trials in Disease Andersen-Tawil syndrome Haemophilia B with anti factor IX – Diagnostics Hepatoblastoma – Diagnostics Familial amyotrophic lateral sclerosis – Trials in Disease Mast cell activation syndrome – Basic Information Crigler-Najjar syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSK5764227 Lovo-B Amy109 Dexrazoxane Bromocriptine Peginterferon Alfa-2A Furosemide Clemastine Skin Autograft Resamirigene Bilparvovec Tenofovir Disoproxil Fumarate Bms-986315 Raxtozinameran Mavacamten Fosfomycin Nicotinamide Telmisartan BI 456906 Cobicistat Ondansetron Hydrochloride More therapies…

    Learn about Your Condition

    Coma Hypertriglyceridaemia Psychotic disorder Fungal infection Bartonellosis Transplantation complication Primary hyperaldosteronism Urinary incontinence Laryngeal cancer stage II Malignant fibrous histiocytoma Glioblastoma multiforme Cardiac failure congestive Crohn's disease Torticollis Frontotemporal dementia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of CAPOX or FOLFOX chemotherapy before surgery in patients with obstructive colon cancer treated with colostomy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Levoleucovorin
    • Capecitabine
    • Fluorouracil
    France

  • Study on Colchicine and Ticagrelor for Preventing Ischemic Stroke in Patients with Atherosclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Colchicine
    France

  • Study on the Effects of Oxycodone and Paracetamol in Patients with Heart Valve or Coronary Artery Disease After Cardiac Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Aortic valve disease
    • Mitral valve disease
    • Tricuspid valve disease
    Investigated Drugs:
    • Oxycodone Hydrochloride
    • Paracetamol
    Finland

  • Study on Treating Knee Osteoarthritis with N-TEC Implant for Patients with Patellofemoral Osteoarthritis

    Recruiting

    2 1 1
    Investigated Drugs:
    • N-Tec
    Croatia Germany

  • Study on Axicabtagene Ciloleucel for Patients with Late Relapse of Diffuse Large B-Cell Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell lymphoma recurrent
    Investigated Drugs:
    • Axicabtagene Ciloleucel
    • Fludarabine
    • Cyclophosphamide
    Spain

  • Study of Tabelecleucel for Patients with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Transplant Treatment Failure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Epstein-Barr virus associated lymphoproliferative disorder
    • Post transplant lymphoproliferative disorder
    Investigated Drugs:
    • Tabelecleucel
    Austria Belgium France Italy Spain
Previous Page
1 … 382 383 384 385 386 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!